{"PubmedArticle":{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM","IndexingMethod":"Manual"},"PMID":{"@attributes":{"Version":"1"},"@text":"1760451"},"DateCompleted":{"Year":"1992","Month":"02","Day":"12"},"DateRevised":{"Year":"2012","Month":"11","Day":"15"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":{"@attributes":{"IssnType":"Print"},"@text":"1042-895X"},"JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"14","Issue":"3","PubDate":{"Year":"1991","Month":"Dec"}},"Title":"Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates","ISOAbbreviation":"Gastroenterol Nurs"},"ArticleTitle":"Dipentum (olsalazine sodium).","Pagination":{"StartPage":"144","EndPage":"147","MedlinePgn":"144-7"},"Abstract":{"AbstractText":["Dipentum (olsalazine sodium), a product by Pharmacia, represents the first oral delivery of sulfa-free 5-aminosalicylic acid therapy available for remission maintenance in sulfasalazineintolerant patients with ulcerative colitis. It provides a safe and well-tolerated treatment regimen that has been shown to be as effective as sulfasalazine in maintaining remission of ulcerative colitis."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Swartz","ForeName":"M L","Initials":"ML"}]},"Language":["eng"],"PublicationTypeList":{"PublicationType":[{"@attributes":{"UI":"D016428"},"@text":"Journal Article"}]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Gastroenterol Nurs","NlmUniqueID":"8915377","ISSNLinking":"1042-895X"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":{"@attributes":{"UI":"D000636"},"@text":"Aminosalicylic Acids"}},{"RegistryNumber":"ULS5I8J03O","NameOfSubstance":{"@attributes":{"UI":"C032587"},"@text":"olsalazine"}}]},"CommentsCorrectionsList":{"CommentsCorrections":[{"@attributes":{"RefType":"CommentIn"},"RefSource":"Gastroenterol Nurs. 1992 Jun;14(6):317.","PMID":{"@attributes":{"Version":"1"},"@text":"1623037"}}]},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":{"@attributes":{"UI":"D000636","MajorTopicYN":"N"},"@text":"Aminosalicylic Acids"},"QualifierName":[{"@attributes":{"UI":"Q000493","MajorTopicYN":"N"},"@text":"pharmacokinetics"},{"@attributes":{"UI":"Q000494","MajorTopicYN":"N"},"@text":"pharmacology"},{"@attributes":{"UI":"Q000627","MajorTopicYN":"Y"},"@text":"therapeutic use"}]},{"DescriptorName":{"@attributes":{"UI":"D006801","MajorTopicYN":"N"},"@text":"Humans"}},{"DescriptorName":{"@attributes":{"UI":"D015212","MajorTopicYN":"N"},"@text":"Inflammatory Bowel Diseases"},"QualifierName":[{"@attributes":{"UI":"Q000188","MajorTopicYN":"Y"},"@text":"drug therapy"}]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"1991","Month":"12","Day":"1"},{"@attributes":{"PubStatus":"medline"},"Year":"1991","Month":"12","Day":"1","Hour":"0","Minute":"1"},{"@attributes":{"PubStatus":"entrez"},"Year":"1991","Month":"12","Day":"1","Hour":"0","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"1760451"}]}}}}